ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

3M will exit branded drugs

November 13, 2006 | APPEARED IN VOLUME 84, ISSUE 46

Acting on a strategic review launched in April, 3M has agreed to sell its global branded pharmaceutical business to three separate buyers for a total of $2.1 billion. The company will sell its U.S., Canadian, and Latin American operations to Graceway Pharmaceuticals, Bristol, Tenn. 3M's European business is going to the Swedish firm Meda, and it is selling its pharma operations in the Asia-Pacific region to the private equity firms Ironbridge Capital and Archer Capital.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment